Version 1
: Received: 5 November 2023 / Approved: 8 November 2023 / Online: 8 November 2023 (15:52:54 CET)
Version 2
: Received: 22 December 2023 / Approved: 22 December 2023 / Online: 22 December 2023 (07:53:29 CET)
Ouchida, T., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.
Ouchida, T., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.
Ouchida, T., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.
Ouchida, T., Suzuki, H., Tanaka, T., Kaneko, M. K., & Kato, Y. (2023). Cx4Mab-1: A Novel Anti-Mouse CXCR4 Monoclonal Antibody for Flow Cytometry. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy.
Abstract
The CXC chemokine receptor 4 (CXCR4, CD184) is a member of the G protein-coupled receptor family that is expressed in most leukocytes. Overexpression of CXCR4 is associated with poor prognosis in not only hematopoietic malignancy but also solid tumors. Because CXCR4 is an attractive target for tumor therapy, reliable preclinical murine models using anti-CXCR4 monoclonal antibodies (mAbs) have been warranted. This study established a novel anti-mouse CXCR4 (mCXCR4) mAb using the Cell-Based Immunization and Screening (CBIS) method. Flow cytometric analysis showed that an anti-mCXCR4 mAb, Cx4Mab-1 (rat IgG2a, kappa), recognized mCXCR4-overexpressed Chinese hamster ovary-K1 (CHO/mCXCR4) cells and endogenously mCXCR4-expressing mouse myeloma P3X63Ag8U.1 (P3U1) cells. Furthermore, Cx4Mab-1 did not recognize mCXCR4-knockout P3U1 cells. The dissociation constants of Cx4Mab-1 for CHO/mCXCR4 and P3U1 were determined as 6.4 × 10−9 M and 2.3 × 10-9 M, respectively, indicating that Cx4Mab-1 possesses a high affinity to both endogenous and exogenous mCXCR4-expressing cells. These results indicate that Cx4Mab-1 could be a useful tool for preclinical mouse models.
Keywords
mouse CXCR4; monoclonal antibody; CBIS method
Subject
Medicine and Pharmacology, Medicine and Pharmacology
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
